-
JCI: Old medicine new results! Scientists have found four drugs that may be effective in treating HIV infection!
Time of Update: 2020-07-15
, July 3, 2020 /PRNewswire/ -- In a recent study published in the international journal Journal of Clinical Investigation , scientists from yale institutions such as Yale University identified fou
-
Cells: What happens when stress comes into being fat...
Time of Update: 2020-07-15
Modern life is full of stress, and we know that long-term stress is not conducive to physical and mental health Recently, scientists from Yale University figured out why stress causes inflammation i
-
mBio: Live vaccine helps prevent lung inflammation in patients with COVID19
Time of Update: 2020-07-15
, July 2, 2020 /PRNewswire/ --- Dr Paul Fidel, professor at the New Orleans School of Dentistry at LSU Health, and Dr Mairi Noverr, professor of microbiology and immunology, have recently shown that
-
How does the rise of the SARS-CoV-2 monogene cause cytokine storms?
Time of Update: 2020-07-15
, July 2, 2020 /PRNewswire / -- Changes in gene expression suggest that possible therapies for the prevention and treatment of COVID-19 are based on a combination of dexamethasone, ostrichol (vitami
-
Immunity experts identified steps to expand and improve antibody testing in THE COVID-19 response
Time of Update: 2020-07-15
, July 6, 2020 / biovalley, , bio-valleys --More than 300 scientists and clinicians from the federal government, industry and academia published a report on the findings and recommendations of the C
-
J Inf Dis: The Mechanism of Listeria Infecting Cells
Time of Update: 2020-07-15
and Cossart at the Pasteur Institute in Paris, focusing on the mechanism by which Listeria invades host mononuclear cells "These breakthroughs may make it possible to develop new treatments to treat listeria in humans and animals in the future," added professor Juan Jos?
-
Immunity: Researchers map the development of human T-cells
Time of Update: 2020-07-15
, July 7, 2020 /PRNewswire- BIOON/ -- Chintan Parekh, M.D., of the Saban Institute at Los Angeles Children's Hospital, led a team that has drawn up a comprehensive roadmap for how T-cells develop i
-
PNAS: Revealing the key molecular mechanisms that induce bile duct cancer in the body
Time of Update: 2020-07-15
, July 6, 2020 / PRNewswire / -- In a recent study published in the Proceedings of the National Academy of Sciences , the International Journal, scientists from institutions such as the National Ce
-
Ribbon herpes vaccine! GlaxoSmithKline (Shingrix) is officially available in China for the prevention of shingles in adults aged 50!
Time of Update: 2020-07-15
, July 02, 2020 /PRNewswire/ -- GlaxoSmithKline (GSK) has announced that shingrix, a shingles vaccine, is officially on the market in China for the prevention of shingles in adults aged 50 and over
-
JEM: Scientists identify a special protein that promotes B-cells to resist pathogen invasion - Pdap1
Time of Update: 2020-07-15
, July 6, 2020 /PRNewswire / -- When bacteria enter the body, the immune system usually reacts quickly against foreign invaders, and one of the important strategies of the body's defense system is
-
IL-6 receptor monoanti-Kevzara, clinical failure of stage III for the treatment of the new coronavirus COVID-19
Time of Update: 2020-07-14
Sanofi and Regeneron announced that the stage III trial of the rheumatoid arthritis drug Kevzara (sarilumab) 400 mg failed to reach its primary secondary and end point in patients who need mechanica
-
Transsexual pustules psoriasis: Imsidolimab named FDA orphan drug
Time of Update: 2020-07-14
Biotech company AnaptysBio announced today that the U.S FDA has awarded the anti-white interleukin 36 receptor (IL-36R) antibody imsidolimab orphan drug for the treatment of patients with dyslezot
-
Leronlimab to prevent the spread of HIV: confirmed in macaques
Time of Update: 2020-07-14
The biotech company CytoDyn developed the leronlimab (PRO 140) as a CCR5 antagonist with the therapeutic potential of HIV and COVID-19 CytoDyn announced today that a preclinical study has shown th
-
NEJM: subcutaneous injection of Nemolizumab to treat specific dermatitis itching
Time of Update: 2020-07-14
Nemolizumab is a subcutaneous injection of human-derived anti-leukal interleukin-31 receptor A monoclonal antibody that can be used to treat itching and inflammation caused by adhesionderitis In the
-
Blood: Key biomarkers for diagnosing autoimmune lymphatic hyperpluse syndrome (ALPS)
Time of Update: 2020-07-14
Auto immune lymphatic hyperploff syndrome (ALPS) is a rare immunodeficiency disease caused by mutations in genes that affect the pathway sapoptosis of exogenous cells ( FAS, FASL , and CASP10 )
-
Gilead Sciences: Long-acting HIV-1 shell inhibitor Lenacapavir (GS-6207) clinically performs well
Time of Update: 2020-07-14
Gilead Sciences today released the latest data from an ongoing Phase 1 clinical study showing that the experimental HIV-1 shell function inhibitor Lenacapavir (GS-6207) is expected to last at least
-
NEJM: New York-area children's multisystem inflammatory syndrome risk with new coronary pneumonia outbreak
Time of Update: 2020-07-14
New York is the hardest hit by the u. new coronapneumonia , and researchers recently examined the association between the incidence of multi-system inflammatory syndrome (MIS-C) in children in the
-
Cell Death Discovery: Medication improves immunotherapy
Time of Update: 2020-07-14
, July 10, 2020 /PRNewswire/ -- BioValley BIOON/--- immunotherapy is a treatment that uses the body's immune system to identify, attack and kill tumor cells, and while it is the most promising new tr
-
Cell: Surprise! Oral microbes hide treatment for intestinal diseases!
Time of Update: 2020-07-14
, July 9, 2020 / /bio-valley- --Although many people delay going to the dentist regularly, recent research suggests that the consequences of doing so may extend beyond tooth decay and root canals F
-
NEJM: Risk of New Coronary Pneumonia and Multisystem Inflammation Syndrome in Children
Time of Update: 2020-07-14
Given the clinical and public health implications of children multi-system inflammatory syndrome (MIS-C), it is important to understand its time-to-time correlation with covid-19 in 2019 resea
